Israel reopens anti-dumping probe on Canadian medical cannabis imports

Investigation signals trade friction as Israel weighs medical cannabis policy shifts and enforcement against unlicensed operations.

FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0

Israel has reopened an anti-dumping investigation into Canadian medical cannabis, according to StratCann. The move comes as Israeli regulators navigate competing pressures: lawmakers are advancing decriminalization measures while enforcement agencies continue raiding unlicensed grow operations, and the Health Ministry has recently updated prescription guidelines and weighed restrictions on smokeable medical flower.

The timing suggests potential concern about import pricing or market dynamics amid domestic policy flux. Israel's medical cannabis sector has seen recent innovation—including a reported "turbo cannabis" breakthrough—but also persistent illegal cultivation, with border police seizing over 10,000 plants across multiple operations since May.

Key to watch: whether the anti-dumping findings align with or complicate Israel's apparent pivot toward broader cannabis access and decriminalization, or whether trade protection serves as a counterweight to loosening domestic rules.